Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
Authors
Keywords
-
Journal
Scientific Reports
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-03-19
DOI
10.1038/srep01485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib in liver cancer
- (2012) Hyun Young Woo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds
- (2012) Alexey A. Nazarov et al. INORGANIC CHEMISTRY
- Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
- (2012) Christian G. Hartinger et al. ORGANOMETALLICS
- A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity
- (2012) Anna Astashkina et al. PHARMACOLOGY & THERAPEUTICS
- Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules
- (2011) Muhammad Hanif et al. CHEMICAL COMMUNICATIONS
- Polynuclear Ruthenium, Osmium and Gold Complexes. The Quest for Innovative Anticancer Chemotherapeutics
- (2011) Christian G. Hartinger et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Metal-based antitumour drugs in the post-genomic era: what comes next?
- (2011) Gianni Sava et al. DALTON TRANSACTIONS
- Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation
- (2011) Bin Wu et al. NUCLEIC ACIDS RESEARCH
- Osmium(ii)–versus ruthenium(ii)–arene carbohydrate-based anticancer compounds: similarities and differences
- (2010) Muhammad Hanif et al. DALTON TRANSACTIONS
- Photoactivated Biological Activity of Transition-Metal Complexes
- (2010) Ulrich Schatzschneider EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model
- (2009) Patrycja Nowak-Sliwinska et al. MICROVASCULAR RESEARCH
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- In Vitro Anticancer Activity and Biologically Relevant Metabolization of Organometallic Ruthenium Complexes with Carbohydrate-Based Ligands
- (2008) Isabella Berger et al. CHEMISTRY-A EUROPEAN JOURNAL
- Osmium Carbonyl Clusters: A New Class of Apoptosis Inducing Agents
- (2008) Kien Voon Kong et al. ChemMedChem
- Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
- (2008) Christian Hartinger et al. CURRENT MEDICINAL CHEMISTRY
- Use of carbon monoxide as a therapeutic agent: promises and challenges
- (2008) Roberta Foresti et al. INTENSIVE CARE MEDICINE
- The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways
- (2008) Soumya Chatterjee et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started